Tert-butyl(2s,4r)-4-hydroxy-2-(methoxymethyl)pyrrolidine-1-carboxylate, 98%, 25g

[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]amine oxalate, 95.0%, 5g

6,7-Dibromoquinoline-5,8-dione, 98%, 250mg

1-tert-Butyl N-(tert-Butoxycarbonyl)-L-aspartate>95.0%(HPLC)(T)5g

2,5-Diethynylpyridine>98.0%(GC)1g

2-amino-9-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one, 98%, 100mg

Colonne capillaire GC ROTI®Cap-5 MS Ultra, 60 m, 0,20 mm, 0,35 µm, 1 pièce(s)

4-[(3-Bromophenyl)methyl]oxan-4-amine hydrochloride, 1g

tert-Butyl 4-(2-iodoethyl)piperidine-1-carboxylate, 95%, 5g

Tert-butyln-[(3r)-spiro[3h-benzofuran-2,4'-piperidine]-3-yl]carbamate, 98%, 1g

Hydroxyde de baryum octahydraté, min 98 %, pa, ACS, ISO, 50 g, emballage plastique.

2,6-DICHLORO-4-FLUOROBENZONITRILE, 95.0%, 100g

2,5-Dibromo-3-chloropyridine, 97.0%, 5g